Athira Pharma Inc (ATHA) USD0.0001
Sell:$0.27Buy:$0.28
$0.01
(2.03%)
Prices delayed by at least 15 minutes
- This stock can be held in a
Stocks and Shares ISASell:$0.27
Buy:$0.28
Change:$0.01
(2.03%)
$0.01
(2.03%)Prices delayed by at least 15 minutes
Sell:$0.27
Buy:$0.28
Change:$0.01
(2.03%)
$0.01
(2.03%)Prices delayed by at least 15 minutes
Director deals
Listed below are trades carried out by directors and other individuals which are required to be notified to the market.
Recent deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 2 January 2025 | Mark James LittonPresident/CEO | Sell Tax related | 25,107 | $0.56 | $14,107.62 | 242,591 |
| 2 January 2025 | Kevin ChurchChief Level Officer | Sell Tax related | 8,510 | $0.56 | $4,781.77 | 130,761 |
| 2 January 2025 | Robert RenningerManager/Officer | Sell Tax related | 2,881 | $0.56 | $1,618.83 | 89,724 |
| 2 January 2025 | Mark F. WorthingtonGeneral Counsel | Sell Tax related | 8,510 | $0.56 | $4,781.77 | 83,735 |
| 2 January 2025 | Javier San MartinOther Level A | Sell Tax related | 10,826 | $0.56 | $6,083.13 | 35,841 |
| 5 September 2024 | Mark James LittonPresident/CEO | Sell Tax related | 5,032 | $0.57 | $2,848.11 | 159,365 |
| 5 September 2024 | Andrew W GengosCFO | Sell Tax related | 1,272 | $0.57 | $719.95 | 97,532 |
| 5 September 2024 | Kevin ChurchChief Level Officer | Sell Tax related | 2,525 | $0.57 | $1,429.15 | 92,684 |
| 5 September 2024 | Mark F. WorthingtonGeneral Counsel | Sell Tax related | 2,525 | $0.57 | $1,429.15 | 51,927 |
| 5 September 2024 | Rachel LeningtonCTO | Sell Tax related | 2,525 | $0.57 | $1,429.15 | 20,870 |
5 most significant deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 24 June 2024 | Kelly A RomanoChairman of the Board | Buy Regular purchase transaction | 27,400 | $2.42 | $66,179.22 | 80,715 |
| 21 June 2024 | Kelly A RomanoChairman of the Board | Buy Regular purchase transaction | 15,000 | $2.26 | $33,871.50 | 53,315 |
| 2 January 2025 | Mark James LittonPresident/CEO | Sell Tax related | 25,107 | $0.56 | $14,107.62 | 242,591 |
| 2 January 2025 | Javier San MartinOther Level A | Sell Tax related | 10,826 | $0.56 | $6,083.13 | 35,841 |
| 2 January 2025 | Kevin ChurchChief Level Officer | Sell Tax related | 8,510 | $0.56 | $4,781.77 | 130,761 |
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.